Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP2T4 Inhibitors

CYP2T4 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the CYP2T4 enzyme, a member of the cytochrome P450 superfamily. The CYP2T4 enzyme is involved in the oxidative metabolism of various substrates, including endogenous molecules such as fatty acids, steroids, and signaling lipids, as well as exogenous substances like drugs and environmental toxins. As with other cytochrome P450 enzymes, CYP2T4 catalyzes the monooxygenation of its substrates, a reaction that introduces an oxygen atom into the substrate molecule. This oxidative process typically converts lipophilic compounds into more hydrophilic forms, facilitating their further metabolism or excretion from the body. The enzyme's activity is significant in various tissues, particularly in organs such as the liver, where cytochrome P450 enzymes play a crucial role in detoxification and metabolic regulation.

Inhibitors of CYP2T4 are generally small molecules designed to interact directly with the enzyme's active site, blocking its ability to catalyze the oxidation of its substrates. These inhibitors may work by occupying the substrate-binding pocket, thus preventing the natural substrates from accessing the catalytic core, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The development of CYP2T4 inhibitors requires a detailed understanding of the enzyme's three-dimensional structure, focusing on the regions essential for substrate recognition and catalytic activity. By inhibiting CYP2T4, researchers can explore the enzyme's specific role in various metabolic pathways and assess the broader implications of its inhibition on the cytochrome P450 network within the body. The study of CYP2T4 inhibitors is important for understanding the enzyme's substrate specificity, its interactions with other metabolic enzymes, and its overall contribution to maintaining metabolic homeostasis. This research enhances our comprehension of the diverse functions of cytochrome P450 enzymes and their significance in the biotransformation and detoxification processes critical for sustaining cellular and systemic health in biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

Broad-spectrum antifungal agent known to inhibit CYP2T4. By hindering the monooxygenase activity, it disrupts the xenobiotic metabolic process, contributing to indirect inhibition of the target protein within intracellular membrane-bounded organelles.

Miconazole

22916-47-8sc-204806
sc-204806A
1 g
5 g
$66.00
$160.00
2
(1)

Imidazole antifungal agent acting as an indirect inhibitor of CYP2T4. Through interference with the monooxygenase activity, it impacts the xenobiotic metabolic process, leading to indirect inhibition of the target protein within the cytoplasm.

Terbinafine

91161-71-6sc-338609
100 mg
$560.00
1
(0)

Antifungal agent in research with inhibitory effects on CYP2T4. By interfering with the monooxygenase activity, it affects the xenobiotic metabolic process and contributes to indirect inhibition of the target protein within intracellular membrane-bounded organelles.

Clotrimazole

23593-75-1sc-3583
sc-3583A
100 mg
1 g
$42.00
$57.00
6
(2)

Imidazole antifungal compound acting as an indirect inhibitor of CYP2T4. It interferes with the monooxygenase activity, impacting the xenobiotic metabolic process and leading to indirect inhibition of the target protein within intracellular membrane-bounded organelles.

Econazole

27220-47-9sc-279013
5 g
$240.00
(0)

Imidazole antifungal agent with inhibitory effects on CYP2T4. Interferes with the monooxygenase activity, impacting the xenobiotic metabolic process and contributing to indirect inhibition of the target protein within the cytoplasm.

Fluconazole

86386-73-4sc-205698
sc-205698A
500 mg
1 g
$54.00
$84.00
14
(1)

Azole antifungal compound acting as an indirect inhibitor of CYP2T4. It disrupts the monooxygenase activity, impacting the xenobiotic metabolic process and contributing to the inhibition of the target protein within the cytoplasm.

Fluoxetine

54910-89-3sc-279166
500 mg
$318.00
9
(1)

Selective serotonin reuptake inhibitor acting as an indirect inhibitor of CYP2T4. It disrupts the xenobiotic metabolic process, affecting the monooxygenase activity and contributing to indirect inhibition of the target protein within intracellular membrane-bounded organelles.

Fluvoxamine

54739-18-3sc-207697
25 mg
$321.00
1
(0)

Selective serotonin reuptake inhibitor with inhibitory effects on CYP2T4. By disrupting the monooxygenase activity, it interferes with the xenobiotic metabolic process, contributing to indirect inhibition of the target protein within the cytoplasm.